Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on mental health, vaccination, telehealth, and racial inequities in healthcare.
Noguchi started her career as a reporter, then an editor, for The Washington Post, primarily covering business and technology. Noguchi joined NPR as a business correspondent in 2008, just before the financial crisis and Great Recession. She has covered a wide range of issues, from the workplace to the earthquake and tsunami in her parents' native Japan in 2011. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award as well as First Place and Best In Show in the radio category from the National Headliner Awards. Her work on medical debt, in partnership with Kaiser Health News, won a 2023 Gerald Loeb award and an award from the National Institutes of Health Care Management.
Noguchi grew up in St. Louis, likes to cook, has a degree in history from Yale and is raising two boys and two rescue dogs outside Washington DC.
-
It's been a bad summer for foodborne illnesses -- from a record-breaking cyclosporiasis outbreak tied to iceberg lettuce to salmonella infections linked to jalapeños.
-
Recent cuts, especially to state and local health departments, are slowing and muddling the response to what's already a record year of outbreaks for diarrhea-causing cyclospora.
-
It can take weeks to confirm a single case of intestinal illness caused by the cyclospora parasite, but the CDC's tally for this year now stands at over 4,100.
-
The FDA retracted its only positive test for cyclospora, the parasite at the center of a multistate outbreak, on Taylor Farms lettuce. But the agency believes lettuce from the brand is still linked.
-
The FDA says lettuce distributed by Taylor Fresh Foods and Taylor Farms de Mexico is still linked to the multistate outbreak of cyclosporiasis. But the source may be difficult to definitively trace. -
The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available. -
Recent studies suggest the weight loss and diabetes drugs may prevent cancer and slow its progression. While weight loss is known to curb cancer risks, GLP-1s may act on other brain and metabolic pathways to prevent cancer. -
The American Cancer Society is changing its screening recommendations for colorectal cancer, suggesting adults begin screening at age 45 and adding blood-based tests as an option.
-
Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have more reason to hope than ever before. -
It's a very treatable form of cancer if caught early, yet younger adults rarely get screened. Patient advocates want more people to talk to their doctors about risk factors and number two.
